Child and Adolescent Immunization Schedule
Recommendations for Ages 18 Years or Younger, United States, 2023
< < Back to Child & Adolescent Immunization Schedule
¶ = Range of recommended ages for all children
†= Range of recommended ages for catch-up immunization
§ = Range of recommended ages for certain high-risk groups
# = Recommended vaccination can begin in this age group
± = Recommended vaccination based on shared clinical decision-making
• = No recommendation/Not applicable
Birth to 15 Months
| Vaccine | Birth | 1 mo | 2 mos | 4 mos | 6 mos | 9 mos | 12 mos | 15 mos |
|---|---|---|---|---|---|---|---|---|
Hepatitis B  (HepB) |
1st dose¶ | ←2nd dose→¶ | † | ←3rd dose→¶ | ||||
| Rotavirus (RV) RV1 (2-dose series); RV5 (3-dose series) |
• | • | 1st dose¶ | 2nd dose¶ | See notes¶ | • | • | • |
| Diphtheria, tetanus, & acellular pertussis (DTaP: <7 yrs) |
• | • | 1st dose¶ | 2nd dose¶ | 3rd dose¶ | † | ←4th dose→¶ | |
| Haemophilus influenzae type b (Hib) |
• | • | 1st dose¶ | 2nd dose¶ | See notes¶ | † | ←3rd or 4th dose, See notes→¶ |
|
| Pneumococcal conjugate (PCV13, PCV15) |
• | • | 1st dose¶ | 2nd dose¶ | 3rd dose¶ | † | ←4th dose→¶ | |
| Inactivated poliovirus (IPV: <18 yrs) |
• | • | 1st dose¶ | 2nd dose¶ | ←3rd dose→¶ | |||
| COVID-19 (1vCOV-mRNA, 2vCOV-mRNA, 1vCOV-aPS) |
• | • | • | • | 2- or 3-dose primary series and booster (See notes)¶ |
|||
| Influenza (IIV4) |
• | • | • | • | Annual vaccination 1 or 2 doses¶ | |||
 Influenza (LAIV4) |
• | • | • | • | • | • | • | • |
| Measles, mumps, rubella (MMR) |
• | • | • | • | See notes§ | ←1st dose→¶ | ||
| Varicella (VAR) |
• | • | • | • | • | • | ←1st dose→¶ | |
| Hepatitis A (HepA) |
• | • | • | • | See notes§ | ←2-dose series, See notes→¶ | ||
| Tetanus, diphtheria, & acellular pertussis (Tdap: ≥7 yrs) |
• | • | • | • | • | • | • | • |
| Human papillomavirus (HPV) |
• | • | • | • | • | • | • | • |
| Meningococcal (MenACWY-D: ≥9 mos, MenACWY-CRM: ≥2 mos, MenACWY-TT: ≥2years) |
• | • | See notes§ | |||||
| Meningococcal B (MenB-4C, MenB-FHbp) |
• | • | • | • | • | • | • | • |
| Pneumococcal polysaccharide (PPSV23) |
• | • | • | • | • | • | • | • |
| Dengue (DEN4CYD: 9-16 yrs) |
• | • | • | • | • | • | • | • |
18 Months to 18 Years
| Vaccines | 18 mos |
19-23 mos |
2-3 yrs |
4-6 yrs |
7-10 yrs |
11-12 yrs |
13-15 yrs |
16 yrs |
17-18 yrs |
|||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Hepatitis B (HepB) |
←3rd dose→¶ | † | ||||||||||||||||||
| Rotavirus (RV) RV1 (2-dose series); RV5 (3-dose series) |
• | • | • | • | • | • | • | • | • | |||||||||||
| Diphtheria, tetanus, & acellular pertussis (DTaP: <7 yrs) |
←4th dose→¶ | † | 5th dose¶ | • | • | • | • | • | ||||||||||||
| Haemophilus influenzae type b (Hib) |
† | † | § | § | ||||||||||||||||
| Pneumococcal conjugate (PCV13, PCV15) |
† | † | § | § | ||||||||||||||||
| Inactivated poliovirus (IPV: <18 yrs) |
←3rd dose→¶ | † | 4th dose¶ | † | † | † | See notes• |
|||||||||||||
| COVID-19 (1vCOV-mRNA, 2vCOV-mRNA, 1vCOV-aPS) |
2- or 3- dose primary series and booster (See notes)¶ | |||||||||||||||||||
| Influenza (IIV4) |
Annual vaccination 1 or 2 doses¶ | ¶ | ¶ | ¶ | ¶ | Annual vaccination 1 dose only¶ | ||||||||||||||
Influenza (LAIV4) |
• | • |
Annual vaccination 1 or 2 doses¶
|
OR ¶ | ¶ | Annual vaccination 1 dose only¶ | ||||||||||||||
| Measles, mumps, rubella (MMR) |
† | 2nd dose¶ | † | |||||||||||||||||
| Varicella (VAR) |
† | 2nd dose¶ | † | |||||||||||||||||
| Hepatitis A (HepA) |
← 2-dose series, See notes→¶ | † | ||||||||||||||||||
| Tetanus, diphtheria, & acellular pertussis (Tdap: ≥7 yrs) |
• | • | • | • | † | 1 dose¶ | § | |||||||||||||
| † | ||||||||||||||||||||
| Human papillomavirus (HPV) |
• | • | • | • | • | • | • | § | § | See notes¶ | † | |||||||||
| • | • | • | # | # | ||||||||||||||||
| Meningococcal (MenACWY-D: ≥9 mos, MenACWY-CRM: ≥2 mos, MenACWY-TT: ≥2years) |
See notes§ | 1st dose¶ | † | 2nd dose¶ | † | |||||||||||||||
| Meningococcal B (MenB-4C, MenB-FHbp) |
• | • | • | • | • | • | • | • | § | See notes§ | ||||||||||
| • | • | • | ± | |||||||||||||||||
| Pneumococcal polysaccharide (PPSV23) |
• | • | See notes§ | |||||||||||||||||
| Dengue (DEN4CYD: 9-16 yrs) |
• | • | • | • | • | • | ¶ | Seropositive in endemic dengue areas (See notes)¶ |
• | |||||||||||